Effect of Mandala Practice on Menopausal Symptoms and Quality of Life
Launched by EMINE KARACAN ·
Trial Information
Current as of September 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether practicing mandala art—a type of meditative drawing—can help reduce symptoms that women often experience during menopause and improve their overall quality of life. Menopause is a natural phase in a woman’s life when her menstrual periods stop, usually in middle age, and it can bring physical and emotional challenges like hot flashes, mood changes, and sleep problems. While there are various treatments available, this study wants to see if mandala practice, which is a safe and creative way to support mental health, could be a helpful and accessible option.
Women who are going through menopause may be eligible to join this study. Although the exact age range listed is unclear, the trial is open to females experiencing menopausal symptoms. Participants would be asked to practice mandala art regularly, and researchers will observe how this affects their symptoms and overall well-being. Since this study is not yet recruiting, interested women should stay informed about when enrollment begins. This research could offer a new, simple way to help women feel better during menopause without using medication.
Gender
FEMALE
Eligibility criteria
About Emine Karacan
Emine Karacan is a clinical trial sponsor dedicated to advancing medical research through the support and coordination of innovative clinical studies. Committed to upholding the highest standards of ethical conduct and scientific rigor, Emine Karacan facilitates the development of novel therapies aimed at improving patient outcomes and contributing to the broader healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Emine Karacan, Asst Prof
Study Chair
Gaziantep Islamic Science and Technology University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported